WO2021192538A1 - Catheter - Google Patents

Catheter Download PDF

Info

Publication number
WO2021192538A1
WO2021192538A1 PCT/JP2021/001476 JP2021001476W WO2021192538A1 WO 2021192538 A1 WO2021192538 A1 WO 2021192538A1 JP 2021001476 W JP2021001476 W JP 2021001476W WO 2021192538 A1 WO2021192538 A1 WO 2021192538A1
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
balloon
tube body
suction port
cerebrospinal fluid
Prior art date
Application number
PCT/JP2021/001476
Other languages
French (fr)
Japanese (ja)
Inventor
大沢悠
澤田賢志
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2021192538A1 publication Critical patent/WO2021192538A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters

Definitions

  • the present invention relates to a catheter that is inserted through the spine and sends a hyperoxygen solution to the brain.
  • Patent Document 1 is a device that is inserted into the spine to remove and return cerebrospinal fluid, and cannot be used for the above-mentioned treatment.
  • the position of the catheter easily moves even though the tip of the catheter reaches the vicinity of the brain, which is not preferable in terms of safety.
  • the present invention has been made to solve the above-mentioned problems, and an object of the present invention is to provide a catheter capable of delivering a high oxygen solution to the brain in a fixed position.
  • the catheter according to the present invention that achieves the above object is a catheter having a tube body to be inserted into a living body.
  • the pipe body has a fluid inlet and outlet at the base end, and has a fluid inlet and outlet.
  • the inlet portion communicates with an injection port formed at the tip end portion of the pipe body, and communicates with the injection port.
  • the outlet portion communicates with a suction port provided on the proximal end side of the injection port. It has a balloon that presses the tube body against the living body.
  • the catheter configured as described above can inject the high oxygen solution around the brain from the injection port, suck the cerebrospinal fluid from the suction port, and send the high oxygen solution to the brain while suppressing the increase in intracranial pressure. .. Further, since the position of the tube body can be fixed by the balloon of the catheter, the tube body and its tip can be prevented from moving in the vicinity of the brain.
  • a plurality of the suction ports may be formed along the length direction of the pipe body.
  • the inlet portion may be connected to the supply portion of the artificial cerebrospinal fluid
  • the outlet portion may be connected to the collection portion of the cerebrospinal fluid. This allows the catheter to inject artificial cerebrospinal fluid from the inlet through the inlet and aspirate cerebrospinal fluid from the suction port through the outlet.
  • the balloon is provided on the proximal end side of the suction port.
  • the suction port is located on the peripheral side of the spinal cord from the balloon, so that the suction port can efficiently suck cerebrospinal fluid at a position with a low risk to the spinal cord.
  • the balloon may be provided at a position near the suction port and at the same circumferential position as the suction port.
  • the catheter can form a space around the suction port by expanding the balloon and pressing the tube body against the wall of the living body cavity, so that the suction port is not blocked. ..
  • the tube body may have an intracranial pressure sensor at the tip. This allows the operator to perform the procedure while checking the intracranial pressure.
  • the tube body may have an oxygen concentration sensor at the tip thereof. This allows the operator to perform the procedure while checking the oxygen concentration at the tip of the tube body.
  • the catheter 10 according to the embodiment of the present invention is inserted into the spinal canal from the lumbar spine, the tip of the catheter 10 is delivered to the vicinity of the brain to inject highly oxygenated artificial cerebrospinal fluid, and the cerebrospinal fluid is injected at the proximal end side.
  • the cerebral infarction is treated by inhaling.
  • the catheter 10 has a long tube body 20.
  • the tube body 20 has an intracranial pressure sensor 22 at its tip.
  • An injection port 30 that opens toward the tip is formed at the tip of the tube body 20.
  • a plurality of suction ports 31 are formed in the middle portion of the tube body 20.
  • the base end of the pipe body 20 is branched into two, an inlet pipe 35 and an outlet pipe 36. Further, a balloon 21 that can be expanded and contracted and a balloon tube 37 that supplies an expansion fluid to the balloon 21 are provided at the base end portion of the tube body 20.
  • An inlet portion 35a is provided at the base end portion of the inlet pipe 35.
  • a liquid supply unit 50 for supplying highly oxygenated artificial cerebrospinal fluid is connected to the inlet portion 35a.
  • An outlet portion 36a is provided at the base end portion of the outlet pipe 36.
  • a cerebrospinal fluid collection unit 52 is connected to the outlet unit 36a.
  • a fluid introduction portion 37a is provided at the base end portion of the balloon tube 37.
  • An expansion fluid supply unit 53 is connected to the fluid introduction unit 37a.
  • a hub can be used as the inlet portion 35a, the outlet portion 36a, and the fluid introduction portion 37a.
  • an injection lumen 40 continuous from the inlet portion 35a of the inlet pipe 35 is formed inside the pipe body 20.
  • the injection lumen 40 extends to the tip of the tube body 20 and communicates with the injection port 30.
  • a suction lumen 41 is formed which is continuous from the outlet portion 36a of the outlet pipe 36 and communicates with the suction port 31.
  • an expansion lumen 42 is formed that is continuous from the fluid introduction portion 37a and communicates with the inside of the balloon 21.
  • the balloon 21 can be expanded by injecting an expansion fluid into the balloon 21 via the expansion lumen 42.
  • the expansion fluid may be a gas or a liquid, and for example, a gas such as helium gas, CO 2 gas, O 2 gas, or laughing gas, physiological saline, a contrast medium, or a mixed liquid thereof can be used.
  • the balloon 21 is a side portion of the tube main body 20 and is arranged on the proximal end side from the suction port 31. As a result, the balloon 21 can press the tube body 20 in the spinal canal in the radial direction. Further, the balloon 21 is provided at the same circumferential position as the suction port 31 and at a position near the suction port 31. The balloon 21 and the suction port 31 are located near the insertion position when the catheter 10 is inserted into the spine.
  • the balloon 21 may have a shape that extends in the opposite direction of the tube body 20. As a result, the balloon 21 can fix the tube body 20 more stably.
  • suction ports 31 are provided.
  • the number of suction ports 31 is not limited to this.
  • the position of the suction port 31 is not limited to the position shown in FIG. 1, and can be provided at an arbitrary position on the tip side of the balloon 21.
  • the tube body 20 and the balloon tube 37 are preferably formed of a material having a certain degree of flexibility.
  • a material having a certain degree of flexibility include polyolefins such as polyethylene, polypropylene, polybutene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, ionomer, or a mixture of two or more thereof, and a soft polyvinyl chloride resin.
  • fluororesins such as polyamide, polyamide elastomer, polyester, polyester elastomer, polyurethane and polytetrafluoroethylene, silicone rubber and latex rubber.
  • the balloon 21 is formed of a thin-film balloon film, and is formed of a flexible material like the tube body 20 and the balloon tube 37.
  • the material of the balloon 21 the ones mentioned above for the tube main body 20 and the balloon tube 37 can be used, or other materials may be used.
  • the catheter 10 is percutaneously inserted into the living body and introduced into the spinal canal through the interlumbar or the gap between the lumbar vertebra and the sacrum. Specifically, the catheter 10 is introduced into the spinal canal using the space of L3-L4, L4-L5, or L5-S1. However, the catheter 10 may be introduced into the spinal canal from a position other than these.
  • the catheter 10 introduced into the spinal canal is inserted toward the brain.
  • the catheter 10 is inserted until the injection port 30 at the tip reaches the vicinity of the brain.
  • the maximum insertion position of the catheter 10 is preferably up to the cisterna magna.
  • the expansion fluid is injected from the expansion fluid supply unit 53 into the balloon 21 via the expansion lumen 42 to expand the balloon 21.
  • the tube body 20 is pressed against the canal wall of the spinal canal P.
  • the tube body 20 is fixed so as not to move in the length direction, so that the catheter 10 does not shift during the treatment, and the safety can be improved.
  • the suction ports 31 may be arranged in a row along the length direction of the pipe body 20, but may be arranged so that the rows are staggered.
  • the shape of the balloon 21 may be a simple circle or a shape that holds a flow passage inside.
  • the highly oxygenated artificial cerebrospinal fluid is supplied from the liquid supply unit 50 and injected from the injection port 30 via the injection lumen 40.
  • the artificial cerebrospinal fluid is supplied to the brain from the injection port 30.
  • the cerebrospinal fluid collection unit 52 is also operated to suck the cerebrospinal fluid in the spinal canal from the suction port 31 via the suction lumen 41.
  • the suction of cerebrospinal fluid is preferably equal to the injection amount of artificial spinal fluid. As a result, an increase in intracranial pressure can be suppressed.
  • the suction port 31 is formed on the base end side of the tube body 20
  • the artificial cerebrospinal fluid injected from the tip of the tube body 20 is not directly sucked, and the artificial cerebrospinal fluid is hyperoxygenated into the brain.
  • the liquid can be reliably supplied.
  • the intracranial pressure measured by the intracranial pressure sensor 22 is checked at any time.
  • an oxygen concentration sensor may be provided at the tip of the tube body 20. By providing the oxygen concentration sensor, the oxygen concentration at the tip of the tube body 20 can be checked at any time.
  • the cerebrospinal fluid collected by the cerebrospinal fluid collection unit 52 is discarded as it is, but the collected cerebrospinal fluid may be passed through a filter and then supplied to the brain together with the artificial cerebrospinal fluid.
  • the cerebrospinal fluid collection unit 52 and the liquid supply unit 50 in FIG. 2 may be the same, or may be distributed through a filter or the like.
  • the balloon 21 can be repeatedly expanded and contracted in the spinal canal. This may increase the fluidity of the cerebrospinal fluid.
  • the balloon 21 is contracted and the catheter 10 is removed from the living body.
  • the catheter 10 is a catheter 10 having a tube body 20 to be inserted into the living body, and the tube body 20 has a fluid inlet portion 35a and a fluid inlet portion 35a and an outlet portion 36a at the proximal end portion.
  • the inlet 35a communicates with the injection port 30 formed at the tip of the tube body 20
  • the outlet 36a communicates with the suction port 31 provided on the proximal end side of the injection port 30, and the tube body 20 is used as a living body.
  • the catheter 10 can suck cerebrospinal fluid from the suction port 31 while injecting the high oxygen solution into the brain from the injection port 30, and can send the high oxygen solution to the brain while suppressing an increase in intracranial pressure. Further, since the position of the tube body 20 can be fixed by the balloon 21 of the catheter 10, the tip of the tube body 20 can be prevented from moving in the vicinity of the brain.
  • a plurality of suction ports 31 may be formed along the length direction of the pipe body 20.
  • the catheter 10 can efficiently suck the cerebrospinal fluid through the suction port 31, so that the increase in the intracranial pressure can be effectively suppressed.
  • the inlet portion 35a may be connected to the liquid supply portion 50, and the outlet portion 36a may be connected to the cerebrospinal fluid collection unit 52.
  • the catheter 10 can inject the liquid from the injection port 30 through the inlet 35a and suck the cerebrospinal fluid from the suction port 31 through the outlet 36a.
  • the balloon 21 may be provided on the proximal end side of the suction port 31.
  • the suction port 31 has more cerebrospinal fluid than the balloon 21 and is arranged on the peripheral side with respect to the spinal cord. Therefore, the suction port 31 efficiently sucks the cerebrospinal fluid at a position having a low risk to the spinal cord. can.
  • the balloon 21 may be provided at a position near the suction port 31 and at the same circumferential position as the suction port 31.
  • the catheter 10 can form a space around the suction port 31 by expanding the balloon 21 and pressing the tube body 20 against the wall of the living body so that the suction port 31 is not blocked. Can be.
  • the tube body 20 may have an intracranial pressure sensor 22 at the tip end portion. This allows the operator to perform the procedure while checking the intracranial pressure.
  • the tube body 20 may have an oxygen concentration sensor at the tip thereof. As a result, the operator can perform the treatment while checking the oxygen concentration at the tip of the tube body 20.
  • the treatment method according to the present embodiment includes a step of introducing the tube body 20 into the spine from the tip having the injection port 30, a step of delivering the tip of the tube body 20 to the vicinity of the brain, and a balloon 21.
  • This treatment method can supply artificial cerebrospinal fluid to the brain while suppressing an increase in intracranial pressure.
  • this treatment method can prevent the position of the tube body 20 from changing when the artificial cerebrospinal fluid is supplied by expanding the balloon 21.
  • this treatment method can prevent the cerebrospinal fluid in the spinal canal below the balloon 21 from becoming impermeable.
  • this treatment method may be able to increase the fluidity of cerebrospinal fluid.
  • a recess 33 may be formed in the tube body 20 and the suction port 31 may be arranged in the recess 33. As a result, it is possible to more reliably prevent the suction port 31 from being blocked in the spinal canal, and it is possible to smoothly suck cerebrospinal fluid and suppress an increase in intracranial pressure.
  • the number of balloons 21 is not limited to one, and a plurality of balloons 21 may be provided.
  • the expansion lumen 42 can be common.
  • One of the plurality of balloons 21 may be expanded outside the body. When the balloon 21 outside the body expands and comes into contact with the outside of the living body, it is possible to more reliably prevent the position of the tube body 20 from shifting.
  • a marker having a contrast medium may be provided at the tip of the tube body 20.
  • the tip of the pipe body 20 can be prevented from being inserted into a predetermined position, for example, above the large tank.
  • the liquid injected from the injection port 30 may be other than the artificial cerebrospinal fluid.
  • the solution for increasing oxygen may be a highly gas-soluble liquid such as fluorocarbon, an emulsion thereof, or a solution having no effect on the living body such as physiological saline. Further, the solution may not be hyperoxygenated, or may be cooled or heated.
  • the catheter 10 may have a safety mechanism in which the intracranial pressure is measured by the intracranial pressure sensor 22 and the inflow of cerebrospinal fluid is stopped according to a preset intracranial pressure threshold. Further, the catheter 10 may have a mechanism for monitoring the value measured by the intracranial pressure sensor 22 and automatically adjusting the balance between infusion and suction of cerebrospinal fluid.
  • At least one of carbon dioxide concentration, carbon dioxide partial pressure (pCO2), pH, mineral components (Na, K, Glucose), creatinine, and cerebrospinal fluid flow rate may have a sensor to measure one.
  • these measured values can be used to calculate oxygen consumption (VO2) and oxygen supply (DO2), which can be used for feedback.
  • VO2 oxygen consumption
  • DO2 oxygen supply
  • a guide wire may be used to insert the catheter 10.
  • the guide wire is inserted into the injection lumen, and the tube body 20 is inserted into the living body while the guide wire precedes the injection lumen.
  • the guide wire is removed.
  • the catheter 10 can also be used for treatments other than cerebral infarction.
  • treatments other than cerebral infarction For example, for cerebral hemorrhage, subarachnoid hemorrhage, hydrocephalus, brain diseases such as Alzheimer's disease, and spinal cord ischemia, it is considered effective to inject a high oxygen solution or forcibly circulate cerebrospinal fluid.
  • the catheter 10 can be used for the disease.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • External Artificial Organs (AREA)

Abstract

Provided is a catheter that can send a high-oxygen solution to the brain in a state where the position of the catheter is fixed. A catheter (10) includes a tube body (20) that is inserted into a living body. The tube body (20) includes, at the proximal end, an entrance part (35A) and an exit part (36a) which are for a fluid. The entrance part (35a) communicates with an injection port (30) that is formed on the distal end of the tube body (20). The exit part (36a) communicates with a suction port (31) that is provided closer to the proximal end than the injection port (30) is. The catheter includes a balloon that presses the tube body (20) against the living body.

Description

カテーテルcatheter
 本発明は、脊椎から挿入されて脳に高酸素溶液を送るカテーテルに関する。 The present invention relates to a catheter that is inserted through the spine and sends a hyperoxygen solution to the brain.
 脳梗塞の治療において、血栓溶解療法や血栓回収療法などの治療方法が確立されている。しかし、出血リスクやアクセス不良による影響から、これらの治療が困難な場合が少なくない。このため、脳梗塞の治療の多くは、内科的治療に留まっている。 In the treatment of cerebral infarction, treatment methods such as thrombolytic therapy and thrombus recovery therapy have been established. However, these treatments are often difficult due to the risk of bleeding and the effects of poor access. For this reason, most treatments for cerebral infarction are limited to medical treatment.
 脳梗塞の治療の一つとして、高酸素化溶液を脳にアプローチし、経血管以外から酸素を送達することが考えられる。この治療には、脊椎から挿入され先端部が脳の近傍まで到達するカテーテルが必要となる。脊椎から挿入されるカテーテルとしては、例えば特許文献1に挙げるようなものがある。 As one of the treatments for cerebral infarction, it is conceivable to approach the brain with an oxygenated solution and deliver oxygen from other than transvascular. This treatment requires a catheter that is inserted through the spine and has a tip that reaches near the brain. Examples of the catheter inserted from the spine include those listed in Patent Document 1.
特開2016-172087号公報Japanese Unexamined Patent Publication No. 2016-172087
 特許文献1記載のカテーテルは、脊椎に挿入されて脳脊髄液を除去及び返還するデバイスであり、前述の治療に用いることができるものではない。前述の治療においては、カテーテルの先端部を脳の近傍まで到達しているにもかかわらず、カテーテルの位置が容易に移動してしまうことが想像でき、安全上好ましくない。 The catheter described in Patent Document 1 is a device that is inserted into the spine to remove and return cerebrospinal fluid, and cannot be used for the above-mentioned treatment. In the above-mentioned treatment, it can be imagined that the position of the catheter easily moves even though the tip of the catheter reaches the vicinity of the brain, which is not preferable in terms of safety.
 本発明は、上述した課題を解決するためになされたものであり、位置を固定された状態で脳に高酸素溶液を送ることができるカテーテルを提供することを目的とする。 The present invention has been made to solve the above-mentioned problems, and an object of the present invention is to provide a catheter capable of delivering a high oxygen solution to the brain in a fixed position.
 上記目的を達成する本発明に係るカテーテルは、生体内に挿入される管本体を有するカテーテルであって、
 前記管本体は基端部に流体の入口部と出口部とを有し、
 前記入口部は前記管本体の先端部に形成される注入口と連通し、
 前記出口部は前記注入口より基端側に設けられる吸引口と連通し、
 前記管本体を生体に押圧するバルーンを有する。
The catheter according to the present invention that achieves the above object is a catheter having a tube body to be inserted into a living body.
The pipe body has a fluid inlet and outlet at the base end, and has a fluid inlet and outlet.
The inlet portion communicates with an injection port formed at the tip end portion of the pipe body, and communicates with the injection port.
The outlet portion communicates with a suction port provided on the proximal end side of the injection port.
It has a balloon that presses the tube body against the living body.
 上記のように構成したカテーテルは、注入口から高酸素溶液を脳周辺に注入しつつ、吸引口から脳脊髄液を吸引でき、頭蓋内圧の上昇を抑えながら脳に高酸素溶液を送ることができる。また、カテーテルは、バルーンで管本体の位置を固定できるので、脳近傍において管本体及びその先端部が動かないようにすることができる。 The catheter configured as described above can inject the high oxygen solution around the brain from the injection port, suck the cerebrospinal fluid from the suction port, and send the high oxygen solution to the brain while suppressing the increase in intracranial pressure. .. Further, since the position of the tube body can be fixed by the balloon of the catheter, the tube body and its tip can be prevented from moving in the vicinity of the brain.
 また、前記吸引口は前記管本体の長さ方向に沿って複数形成されるようにしてもよい。これにより、カテーテルは、吸引口で効率よく脳脊髄液を吸引できるので、頭蓋内圧の上昇を効果的に抑えることができる。 Further, a plurality of the suction ports may be formed along the length direction of the pipe body. As a result, the catheter can efficiently suck cerebrospinal fluid through the suction port, so that the increase in intracranial pressure can be effectively suppressed.
 また、前記入口部は人工髄液の供給部に接続され、前記出口部は脳脊髄液の回収部に接続されるようにしてもよい。これにより、カテーテルは、入口部を介して注入口から人工髄液を注入し、吸引口から出口部を介して脳脊髄液を吸引できる。 Further, the inlet portion may be connected to the supply portion of the artificial cerebrospinal fluid, and the outlet portion may be connected to the collection portion of the cerebrospinal fluid. This allows the catheter to inject artificial cerebrospinal fluid from the inlet through the inlet and aspirate cerebrospinal fluid from the suction port through the outlet.
 また、前記バルーンは、前記吸引口より基端側に設けられる。これにより、吸引口は、バルーンより脊髄の末梢側に配置されるので、吸引口は脳脊髄液を効率よく、脊髄に対してリスクの低い位置で吸引できる。 Further, the balloon is provided on the proximal end side of the suction port. As a result, the suction port is located on the peripheral side of the spinal cord from the balloon, so that the suction port can efficiently suck cerebrospinal fluid at a position with a low risk to the spinal cord.
 また、前記バルーンは前記吸引口の近傍位置であって、前記吸引口と同じ周方向位置に設けられるようにしてもよい。これにより、カテーテルは、バルーンが拡張して管本体が生体内腔壁に押し付けられることにより、吸引口の周辺にスペースを形成することができ、吸引口が塞がれないようにすることができる。 Further, the balloon may be provided at a position near the suction port and at the same circumferential position as the suction port. As a result, the catheter can form a space around the suction port by expanding the balloon and pressing the tube body against the wall of the living body cavity, so that the suction port is not blocked. ..
 また、前記管本体は、先端部に頭蓋内圧センサーを有するようにしてもよい。これにより、術者は、頭蓋内圧を確認しながら処置を行うことができる。 Further, the tube body may have an intracranial pressure sensor at the tip. This allows the operator to perform the procedure while checking the intracranial pressure.
 また、前記管本体は、先端部に酸素濃度センサーを有するようにしてもよい。これにより、術者は、管本体の先端部における酸素濃度を確認しながら処置を行うことができる。 Further, the tube body may have an oxygen concentration sensor at the tip thereof. This allows the operator to perform the procedure while checking the oxygen concentration at the tip of the tube body.
本実施形態のカテーテルの正面図である。It is a front view of the catheter of this embodiment. カテーテルのうちバルーン及び吸引口が設けられる付近の拡大断面図である。It is an enlarged cross-sectional view of the vicinity where a balloon and a suction port are provided in a catheter. 脊柱管内においてバルーンを拡張した状態のカテーテルの模式的な拡大図である。It is a schematic enlarged view of the catheter in the state where the balloon is expanded in the spinal canal. 管本体に凹部を設けたカテーテルのうち吸引口付近の正面図である。It is a front view of the vicinity of a suction port of a catheter provided with a recess in the tube body.
 以下、図面を参照して、本発明の実施の形態を説明する。なお、図面の寸法比率は、説明の都合上、誇張されて実際の比率とは異なる場合がある。また、本明細書では、カテーテル10の生体に挿入する側を「先端」若しくは「先端側」、操作する手元側を「基端」若しくは「基端側」と称することとする。 Hereinafter, embodiments of the present invention will be described with reference to the drawings. The dimensional ratios in the drawings may be exaggerated and differ from the actual ratios for convenience of explanation. Further, in the present specification, the side of the catheter 10 to be inserted into the living body is referred to as "tip" or "tip side", and the hand side to be operated is referred to as "base end" or "base end side".
 本発明の実施形態に係るカテーテル10は、腰椎から脊柱管に挿入され、先端部が脳の近傍まで送達されて高酸素化した人工髄液を注入すると共に、基端側の部分で脳脊髄液を吸引することで、脳梗塞の治療を行う。 The catheter 10 according to the embodiment of the present invention is inserted into the spinal canal from the lumbar spine, the tip of the catheter 10 is delivered to the vicinity of the brain to inject highly oxygenated artificial cerebrospinal fluid, and the cerebrospinal fluid is injected at the proximal end side. The cerebral infarction is treated by inhaling.
 図1に示すように、カテーテル10は、長尺な管本体20を有している。管本体20は、先端部に頭蓋内圧センサー22を有している。管本体20の先端部には、先端に向かって開口する注入口30が形成されている。管本体20の中間部には、複数の吸引口31が形成されている。 As shown in FIG. 1, the catheter 10 has a long tube body 20. The tube body 20 has an intracranial pressure sensor 22 at its tip. An injection port 30 that opens toward the tip is formed at the tip of the tube body 20. A plurality of suction ports 31 are formed in the middle portion of the tube body 20.
 管本体20の基端部は、入口管35と出口管36の2つに分岐している。また、管本体20の基端部には、拡張、収縮可能なバルーン21と、このバルーン21に拡張用流体を供給するバルーン用管37とが設けられる。 The base end of the pipe body 20 is branched into two, an inlet pipe 35 and an outlet pipe 36. Further, a balloon 21 that can be expanded and contracted and a balloon tube 37 that supplies an expansion fluid to the balloon 21 are provided at the base end portion of the tube body 20.
 入口管35の基端部には入口部35aが設けられる。入口部35aには、高酸素化された人工髄液を供給する液体供給部50が接続される。出口管36の基端部には出口部36aが設けられる。出口部36aには、髄液回収部52が接続される。バルーン用管37の基端部には流体導入部37aが設けられる。流体導入部37aには、拡張用流体供給部53が接続される。入口部35aや出口部36a及び流体導入部37aとしては、例えばハブを用いることができる。 An inlet portion 35a is provided at the base end portion of the inlet pipe 35. A liquid supply unit 50 for supplying highly oxygenated artificial cerebrospinal fluid is connected to the inlet portion 35a. An outlet portion 36a is provided at the base end portion of the outlet pipe 36. A cerebrospinal fluid collection unit 52 is connected to the outlet unit 36a. A fluid introduction portion 37a is provided at the base end portion of the balloon tube 37. An expansion fluid supply unit 53 is connected to the fluid introduction unit 37a. As the inlet portion 35a, the outlet portion 36a, and the fluid introduction portion 37a, for example, a hub can be used.
 図2に示すように、管本体20の内部には、入口管35の入口部35aから連続する注入ルーメン40が形成されている。注入ルーメン40は、管本体20の先端部まで延び、注入口30に連通する。また、管本体20の内部には、出口管36の出口部36aから連続し吸引口31に連通する吸引ルーメン41が形成されている。 As shown in FIG. 2, an injection lumen 40 continuous from the inlet portion 35a of the inlet pipe 35 is formed inside the pipe body 20. The injection lumen 40 extends to the tip of the tube body 20 and communicates with the injection port 30. Further, inside the pipe body 20, a suction lumen 41 is formed which is continuous from the outlet portion 36a of the outlet pipe 36 and communicates with the suction port 31.
 バルーン用管37の内部には、流体導入部37aから連続しバルーン21の内部と連通する拡張ルーメン42が形成されている。拡張ルーメン42を介してバルーン21に拡張用流体を注入することで、バルーン21を拡張させることができる。拡張用流体は気体でも液体でもよく、例えばヘリウムガス、COガス、Oガス、笑気ガス等の気体や、生理食塩水、造影剤、及びその混合した液体を用いることができる。 Inside the balloon tube 37, an expansion lumen 42 is formed that is continuous from the fluid introduction portion 37a and communicates with the inside of the balloon 21. The balloon 21 can be expanded by injecting an expansion fluid into the balloon 21 via the expansion lumen 42. The expansion fluid may be a gas or a liquid, and for example, a gas such as helium gas, CO 2 gas, O 2 gas, or laughing gas, physiological saline, a contrast medium, or a mixed liquid thereof can be used.
 バルーン21は、管本体20の側部であって吸引口31より基端側に配置されている。これにより、バルーン21は、脊柱管において管本体20を径方向に押圧することができる。また、バルーン21は、吸引口31と同じ周方向位置であって、吸引口31の近傍位置に設けられている。バルーン21及び吸引口31は、カテーテル10が脊椎に挿入された際に、挿入位置近傍に位置する。 The balloon 21 is a side portion of the tube main body 20 and is arranged on the proximal end side from the suction port 31. As a result, the balloon 21 can press the tube body 20 in the spinal canal in the radial direction. Further, the balloon 21 is provided at the same circumferential position as the suction port 31 and at a position near the suction port 31. The balloon 21 and the suction port 31 are located near the insertion position when the catheter 10 is inserted into the spine.
 バルーン21は、管本体20の反対方向にも拡張する形状であってもよい。これにより、バルーン21は、管本体20をより安定して固定できる。 The balloon 21 may have a shape that extends in the opposite direction of the tube body 20. As a result, the balloon 21 can fix the tube body 20 more stably.
 本実施形態において吸引口31は4つ設けられている。ただし、吸引口31の数はこれに限られない。また、吸引口31の位置についても、図1に示した位置に限られず、バルーン21より先端側の任意の位置に設けることができる。 In this embodiment, four suction ports 31 are provided. However, the number of suction ports 31 is not limited to this. Further, the position of the suction port 31 is not limited to the position shown in FIG. 1, and can be provided at an arbitrary position on the tip side of the balloon 21.
 管本体20及びバルーン用管37は、ある程度の可撓性を有する材料により形成されるのが好ましい。そのような材料としては、例えば、ポリエチレン、ポリプロピレン、ポリブテン、エチレン-プロピレン共重合体、エチレン-酢酸ビニル共重合体、アイオノマー、あるいはこれら二種以上の混合物等のポリオレフィンや、軟質ポリ塩化ビニル樹脂、ポリアミド、ポリアミドエラストマー、ポリエステル、ポリエステルエラストマー、ポリウレタン、ポリテトラフルオロエチレン等のフッ素樹脂、シリコーンゴム、ラテックスゴム等が挙げられる。 The tube body 20 and the balloon tube 37 are preferably formed of a material having a certain degree of flexibility. Examples of such a material include polyolefins such as polyethylene, polypropylene, polybutene, ethylene-propylene copolymer, ethylene-vinyl acetate copolymer, ionomer, or a mixture of two or more thereof, and a soft polyvinyl chloride resin. Examples thereof include fluororesins such as polyamide, polyamide elastomer, polyester, polyester elastomer, polyurethane and polytetrafluoroethylene, silicone rubber and latex rubber.
 バルーン21は、薄膜状のバルーン膜によって形成されており、管本体20やバルーン用管37と同様に、可撓性を有する材料によって形成される。バルーン21の材質には、管本体20及びバルーン用管37について上で挙げたものを用いることができ、また、それ以外であってもよい。 The balloon 21 is formed of a thin-film balloon film, and is formed of a flexible material like the tube body 20 and the balloon tube 37. As the material of the balloon 21, the ones mentioned above for the tube main body 20 and the balloon tube 37 can be used, or other materials may be used.
 次に、本実施形態のカテーテル10を用いた処置方法について説明する。カテーテル10は、経皮的に生体内に挿入され、腰椎間あるいは腰椎と仙骨間の隙間から脊柱管内に導入される。具体的には、カテーテル10は、L3-L4、L4-L5、あるいはL5-S1の空間を用いて脊柱管内に導入される。ただし、カテーテル10は、これら以外の位置から脊柱管内に導入されてもよい。 Next, a treatment method using the catheter 10 of the present embodiment will be described. The catheter 10 is percutaneously inserted into the living body and introduced into the spinal canal through the interlumbar or the gap between the lumbar vertebra and the sacrum. Specifically, the catheter 10 is introduced into the spinal canal using the space of L3-L4, L4-L5, or L5-S1. However, the catheter 10 may be introduced into the spinal canal from a position other than these.
 脊柱管内に導入されたカテーテル10は、脳に向かって挿入される。カテーテル10は、先端部の注入口30が脳の近傍に到達するまで挿入される。カテーテル10の最大挿入位置は、大槽までとするのが望ましい。 The catheter 10 introduced into the spinal canal is inserted toward the brain. The catheter 10 is inserted until the injection port 30 at the tip reaches the vicinity of the brain. The maximum insertion position of the catheter 10 is preferably up to the cisterna magna.
 カテーテル10を挿入したら、拡張用流体供給部53から拡張ルーメン42を介してバルーン21に対し拡張用流体を注入し、バルーン21を拡張させる。図3に示すように、
脊柱管P内において、バルーン21が拡張すると、管本体20は脊柱管Pの管壁に押し付けられる。これにより、管本体20は長さ方向に動かないように固定されて、治療中にカテーテル10がずれないようにし、安全性を高くすることができる。
After inserting the catheter 10, the expansion fluid is injected from the expansion fluid supply unit 53 into the balloon 21 via the expansion lumen 42 to expand the balloon 21. As shown in FIG.
When the balloon 21 expands in the spinal canal P, the tube body 20 is pressed against the canal wall of the spinal canal P. As a result, the tube body 20 is fixed so as not to move in the length direction, so that the catheter 10 does not shift during the treatment, and the safety can be improved.
 また、バルーン21が拡張して管本体20が脊柱管Pの管壁に押し付けられることで、吸引口31と脊柱管Pの管壁との間に隙間が形成される。このため、吸引口31が塞がらないようにして、吸引口31から円滑に脳脊髄液を吸引することができる。また、吸引口31は管本体20の長さ方向に沿って複数形成されているので、脳脊髄液を効率よく吸引し、頭蓋内圧の上昇を抑えることができる。吸引口31は、管本体20の長さ方向に沿って一列に並んでいてもよいが、列をずらした配置になっていてもよい。 Further, when the balloon 21 expands and the tube body 20 is pressed against the tube wall of the spinal canal P, a gap is formed between the suction port 31 and the tube wall of the spinal canal P. Therefore, the cerebrospinal fluid can be smoothly sucked from the suction port 31 without blocking the suction port 31. Further, since a plurality of suction ports 31 are formed along the length direction of the tube body 20, cerebrospinal fluid can be efficiently sucked and an increase in intracranial pressure can be suppressed. The suction ports 31 may be arranged in a row along the length direction of the pipe body 20, but may be arranged so that the rows are staggered.
 バルーン21は、脊柱管内を完全には閉塞しないことが望ましい。これにより、バルーン21より下部の脊柱管内の脳脊髄液が流動不能となることを防止できる。よって、バルーン21の形状は、単純な丸であってもよいし、中に流通路を保持する形状であってもよい。 It is desirable that the balloon 21 does not completely occlude the inside of the spinal canal. As a result, it is possible to prevent the cerebrospinal fluid in the spinal canal below the balloon 21 from becoming impermeable. Therefore, the shape of the balloon 21 may be a simple circle or a shape that holds a flow passage inside.
 バルーン21を拡張させたら、液体供給部50から高酸素化された人工髄液を供給し、注入ルーメン40を介して注入口30から注入する。人工髄液は、注入口30から脳に供給される。人工髄液を供給する際には、髄液回収部52も動作させ、吸引口31から吸引ルーメン41を介して脊柱管内の脳脊髄液を吸引する。脳脊髄液の吸引は、人工髄液の注入量と同等とすることが好ましい。これにより、頭蓋内圧の上昇を抑えることができる。吸引口31は管本体20の基端側の部分に形成されているので、管本体20の先端部から注入される人工髄液を直接吸引することがなく、脳に高酸素化された人工髄液を確実に供給できる。人工髄液の供給及び脳脊髄液の吸引中は、頭蓋内圧センサー22により測定される頭蓋内圧が随時チェックされる。また、管本体20の先端部には、酸素濃度センサーが設けられてもよい。酸素濃度センサーを設けることで、管本体20の先端部における酸素濃度を随時チェックできる。 After the balloon 21 is expanded, the highly oxygenated artificial cerebrospinal fluid is supplied from the liquid supply unit 50 and injected from the injection port 30 via the injection lumen 40. The artificial cerebrospinal fluid is supplied to the brain from the injection port 30. When supplying the artificial cerebrospinal fluid, the cerebrospinal fluid collection unit 52 is also operated to suck the cerebrospinal fluid in the spinal canal from the suction port 31 via the suction lumen 41. The suction of cerebrospinal fluid is preferably equal to the injection amount of artificial spinal fluid. As a result, an increase in intracranial pressure can be suppressed. Since the suction port 31 is formed on the base end side of the tube body 20, the artificial cerebrospinal fluid injected from the tip of the tube body 20 is not directly sucked, and the artificial cerebrospinal fluid is hyperoxygenated into the brain. The liquid can be reliably supplied. During the supply of artificial cerebrospinal fluid and the suction of cerebrospinal fluid, the intracranial pressure measured by the intracranial pressure sensor 22 is checked at any time. Further, an oxygen concentration sensor may be provided at the tip of the tube body 20. By providing the oxygen concentration sensor, the oxygen concentration at the tip of the tube body 20 can be checked at any time.
 髄液回収部52で回収された脳脊髄液は、そのまま廃棄されるが、回収した脳脊髄液をフィルタに通した上で、人工髄液と共に脳に対し供給するようにしてもよい。その場合には、図2の髄液回収部52と液体供給部50が同一であってもよいし、フィルタなどを介して流通していてもよい。 The cerebrospinal fluid collected by the cerebrospinal fluid collection unit 52 is discarded as it is, but the collected cerebrospinal fluid may be passed through a filter and then supplied to the brain together with the artificial cerebrospinal fluid. In that case, the cerebrospinal fluid collection unit 52 and the liquid supply unit 50 in FIG. 2 may be the same, or may be distributed through a filter or the like.
 また、脳脊髄液の流動性が悪い場合には、脊柱管内でバルーン21の拡張と収縮を繰り返し行うこともできる。これにより、脳脊髄液の流動性を高くできる場合がある。 In addition, when the fluidity of cerebrospinal fluid is poor, the balloon 21 can be repeatedly expanded and contracted in the spinal canal. This may increase the fluidity of the cerebrospinal fluid.
 人工髄液の供給が終了したら、バルーン21を収縮させ、カテーテル10を生体内から抜去する。 When the supply of artificial cerebrospinal fluid is completed, the balloon 21 is contracted and the catheter 10 is removed from the living body.
 以上のように、本実施形態に係るカテーテル10は、生体内に挿入される管本体20を有するカテーテル10であって、管本体20は基端部に流体の入口部35aと出口部36aとを有し、入口部35aは管本体20の先端部に形成される注入口30と連通し、出口部36aは注入口30より基端側に設けられる吸引口31と連通し、管本体20を生体に押圧するバルーン21を有する。このカテーテル10は、注入口30から高酸素溶液を脳に注入しつつ、吸引口31から脳脊髄液を吸引でき、頭蓋内圧の上昇を抑えながら脳に高酸素溶液を送ることができる。また、カテーテル10は、バルーン21で管本体20の位置を固定できるので、脳近傍において管本体20の先端部が動かないようにすることができる。 As described above, the catheter 10 according to the present embodiment is a catheter 10 having a tube body 20 to be inserted into the living body, and the tube body 20 has a fluid inlet portion 35a and a fluid inlet portion 35a and an outlet portion 36a at the proximal end portion. The inlet 35a communicates with the injection port 30 formed at the tip of the tube body 20, the outlet 36a communicates with the suction port 31 provided on the proximal end side of the injection port 30, and the tube body 20 is used as a living body. Has a balloon 21 that presses against. The catheter 10 can suck cerebrospinal fluid from the suction port 31 while injecting the high oxygen solution into the brain from the injection port 30, and can send the high oxygen solution to the brain while suppressing an increase in intracranial pressure. Further, since the position of the tube body 20 can be fixed by the balloon 21 of the catheter 10, the tip of the tube body 20 can be prevented from moving in the vicinity of the brain.
 また、吸引口31は管本体20の長さ方向に沿って複数形成されるようにしてもよい。これにより、カテーテル10は、吸引口31で効率よく脳脊髄液を吸引できるので、頭蓋内圧の上昇を効果的に抑えることができる。 Further, a plurality of suction ports 31 may be formed along the length direction of the pipe body 20. As a result, the catheter 10 can efficiently suck the cerebrospinal fluid through the suction port 31, so that the increase in the intracranial pressure can be effectively suppressed.
 また、入口部35aは液体供給部50に接続され、出口部36aは髄液回収部52に接続されるようにしてもよい。これにより、カテーテル10は、入口部35aを介して注入口30から液体を注入し、吸引口31から出口部36aを介して脳脊髄液を吸引できる。 Further, the inlet portion 35a may be connected to the liquid supply portion 50, and the outlet portion 36a may be connected to the cerebrospinal fluid collection unit 52. As a result, the catheter 10 can inject the liquid from the injection port 30 through the inlet 35a and suck the cerebrospinal fluid from the suction port 31 through the outlet 36a.
 また、バルーン21は、吸引口31より基端側に設けられるようにしてもよい。これにより、吸引口31は、バルーン21より脳脊髄液が多く、脊髄に対して末梢側に配置されるので、吸引口31は脳脊髄液を効率よく、脊髄に対してリスクの低い位置で吸引できる。 Further, the balloon 21 may be provided on the proximal end side of the suction port 31. As a result, the suction port 31 has more cerebrospinal fluid than the balloon 21 and is arranged on the peripheral side with respect to the spinal cord. Therefore, the suction port 31 efficiently sucks the cerebrospinal fluid at a position having a low risk to the spinal cord. can.
 また、バルーン21は吸引口31の近傍位置であって、吸引口31と同じ周方向位置に設けられるようにしてもよい。これにより、カテーテル10は、バルーン21が拡張して管本体20が生体内腔壁に押し付けられることにより、吸引口31の周辺にスペースを形成することができ、吸引口31が塞がれないようにすることができる。 Further, the balloon 21 may be provided at a position near the suction port 31 and at the same circumferential position as the suction port 31. As a result, the catheter 10 can form a space around the suction port 31 by expanding the balloon 21 and pressing the tube body 20 against the wall of the living body so that the suction port 31 is not blocked. Can be.
 また、管本体20は、先端部に頭蓋内圧センサー22を有するようにしてもよい。これにより、術者は、頭蓋内圧を確認しながら処置を行うことができる。 Further, the tube body 20 may have an intracranial pressure sensor 22 at the tip end portion. This allows the operator to perform the procedure while checking the intracranial pressure.
 また、管本体20は、先端部に酸素濃度センサーを有するようにしてもよい。これにより、術者は、管本体20の先端部における酸素濃度を確認しながら処置を行うことができる。 Further, the tube body 20 may have an oxygen concentration sensor at the tip thereof. As a result, the operator can perform the treatment while checking the oxygen concentration at the tip of the tube body 20.
 また、本実施形態に係る処置方法は、注入口30を有する先端部から管本体20を脊椎内に導入するステップと、管本体20の先端部を脳の近傍まで送達するステップと、バルーン21を拡張させて管本体20を脊椎内に押し付け固定するステップと、注入口30から人工髄液を注入し、注入口30より基端側に設けられる吸引口31から脳脊髄液を吸引するステップと、を有する。この処置方法は、頭蓋内圧の上昇を抑えながら脳に人工髄液を供給できる。また、この処置方法は、バルーン21の拡張により、人工髄液の供給時に管本体20の位置が変化しないようにすることができる。 Further, the treatment method according to the present embodiment includes a step of introducing the tube body 20 into the spine from the tip having the injection port 30, a step of delivering the tip of the tube body 20 to the vicinity of the brain, and a balloon 21. A step of expanding and pressing and fixing the tube body 20 into the spine, a step of injecting artificial spinal fluid from the injection port 30, and a step of sucking cerebrospinal fluid from a suction port 31 provided on the proximal end side of the injection port 30. Has. This treatment method can supply artificial cerebrospinal fluid to the brain while suppressing an increase in intracranial pressure. In addition, this treatment method can prevent the position of the tube body 20 from changing when the artificial cerebrospinal fluid is supplied by expanding the balloon 21.
 また、バルーン21の拡張時に、バルーン21が生体内腔を完全には閉塞しないようにすることもできる。これにより、この処置方法は、バルーン21より下部の脊柱管内の脳脊髄液が流動不能となることを防止できる。 It is also possible to prevent the balloon 21 from completely obstructing the living body cavity when the balloon 21 is expanded. Thereby, this treatment method can prevent the cerebrospinal fluid in the spinal canal below the balloon 21 from becoming impermeable.
 また、生体内腔でバルーン21の拡張と収縮を繰り返し行うこともできる。これにより、この処置方法は、脳脊髄液の流動性を高くできる場合がある。 It is also possible to repeatedly expand and contract the balloon 21 in the lumen of the living body. Thereby, this treatment method may be able to increase the fluidity of cerebrospinal fluid.
 なお、本発明は、上述した実施形態のみに限定されるものではなく、本発明の技術的思想内において当業者により種々変更が可能である。図4に示すように、管本体20に凹部33を形成し、凹部33内に吸引口31を配置するようにしてもよい。これにより、脊柱管内において吸引口31が塞がることをより確実に防止でき、円滑に脳脊髄液を吸引して頭蓋内圧の上昇を抑えることができる。 The present invention is not limited to the above-described embodiment, and various modifications can be made by those skilled in the art within the technical idea of the present invention. As shown in FIG. 4, a recess 33 may be formed in the tube body 20 and the suction port 31 may be arranged in the recess 33. As a result, it is possible to more reliably prevent the suction port 31 from being blocked in the spinal canal, and it is possible to smoothly suck cerebrospinal fluid and suppress an increase in intracranial pressure.
 また、バルーン21は、1つに限られず、複数設けられてもよい。バルーン21を複数設ける場合、拡張ルーメン42は共通とすることができる。複数設けられるバルーン21の一つは、体外で拡張してもよい。体外のバルーン21が拡張して生体の外側に当接することで、管本体20の位置がずれることをより確実に防止できる。 Further, the number of balloons 21 is not limited to one, and a plurality of balloons 21 may be provided. When a plurality of balloons 21 are provided, the expansion lumen 42 can be common. One of the plurality of balloons 21 may be expanded outside the body. When the balloon 21 outside the body expands and comes into contact with the outside of the living body, it is possible to more reliably prevent the position of the tube body 20 from shifting.
 また、管本体20の先端部に、造影性を有するマーカーを設けてもよい。これにより、管本体20の先端部が所定の位置、例えば大槽より上まで挿入されないようにすることができる。 Further, a marker having a contrast medium may be provided at the tip of the tube body 20. As a result, the tip of the pipe body 20 can be prevented from being inserted into a predetermined position, for example, above the large tank.
 また、注入口30から注入される液体は、人工髄液以外でもよい。高酸素化する溶液は、フルオロカーボンなどの気体溶解性の高い液体またはそのエマルジョン、生理食塩水など生体に影響のない溶液でもよい。また、溶液は高酸素化されていなくてもよいし、冷却あるいは加温されていてもよい。 Further, the liquid injected from the injection port 30 may be other than the artificial cerebrospinal fluid. The solution for increasing oxygen may be a highly gas-soluble liquid such as fluorocarbon, an emulsion thereof, or a solution having no effect on the living body such as physiological saline. Further, the solution may not be hyperoxygenated, or may be cooled or heated.
 また、カテーテル10は、頭蓋内圧センサー22で頭蓋内圧を測定し、予め設定した頭蓋内圧の閾値に応じて脳脊髄液の流入がストップする安全機構を有していてもよい。また、カテーテル10は、頭蓋内圧センサー22で測定した値をモニタリングし、脳脊髄液の注入と吸引のバランスを自動で調整する機構を有していてもよい。 Further, the catheter 10 may have a safety mechanism in which the intracranial pressure is measured by the intracranial pressure sensor 22 and the inflow of cerebrospinal fluid is stopped according to a preset intracranial pressure threshold. Further, the catheter 10 may have a mechanism for monitoring the value measured by the intracranial pressure sensor 22 and automatically adjusting the balance between infusion and suction of cerebrospinal fluid.
 また、頭蓋内圧センサー22と併せて、あるいはこれに代えて、二酸化炭素濃度、二酸化炭素分圧(pCO2)、pH、ミネラル成分(Na、K、Glucose)、クレアチニン、脳脊髄液流量のうち少なくとも1つを測定するセンサーを有していてもよい。また、これらの測定値を使って、酸素消費量(VO2)、酸素供給量(DO2)を算出し、フィードバックに使用することができる。センサーは例えば、光ファイバー型のセンサーをカテーテル10に組み込むことで、カテーテル10の任意の位置での値を測定することが可能になる。 Also, in combination with or in place of the intracranial pressure sensor 22, at least one of carbon dioxide concentration, carbon dioxide partial pressure (pCO2), pH, mineral components (Na, K, Glucose), creatinine, and cerebrospinal fluid flow rate. It may have a sensor to measure one. In addition, these measured values can be used to calculate oxygen consumption (VO2) and oxygen supply (DO2), which can be used for feedback. For example, by incorporating an optical fiber type sensor into the catheter 10, the sensor can measure a value at an arbitrary position of the catheter 10.
 また、カテーテル10を挿入するためにガイドワイヤを用いてもよい。この場合、注入ルーメンにガイドワイヤを挿通し、ガイドワイヤを先行させながら管本体20を生体内に挿入する。管本体20が所定の位置まで到達したら、ガイドワイヤは抜去される。 Alternatively, a guide wire may be used to insert the catheter 10. In this case, the guide wire is inserted into the injection lumen, and the tube body 20 is inserted into the living body while the guide wire precedes the injection lumen. When the tube body 20 reaches a predetermined position, the guide wire is removed.
 また、カテーテル10は、脳梗塞以外の治療に用いることもできる。例えば、脳出血、くも膜下出血、水頭症、アルツハイマーなどの脳疾患、及び脊髄虚血についても、高酸素溶液を注入することや脳脊髄液を強制的に循環させることが有効と考えられ、これらの疾患についてカテーテル10を用いることができる。 The catheter 10 can also be used for treatments other than cerebral infarction. For example, for cerebral hemorrhage, subarachnoid hemorrhage, hydrocephalus, brain diseases such as Alzheimer's disease, and spinal cord ischemia, it is considered effective to inject a high oxygen solution or forcibly circulate cerebrospinal fluid. The catheter 10 can be used for the disease.
 なお、本出願は、2020年3月27日に出願された日本特許出願2020-58236号に基づいており、それらの開示内容は、参照され、全体として、組み入れられている。 Note that this application is based on Japanese Patent Application No. 2020-58236 filed on March 27, 2020, and the disclosure contents thereof are referred to and incorporated as a whole.
 10  カテーテル
 20  管本体
 21  バルーン
 22  頭蓋内圧センサー
 30  注入口
 31  吸引口
 33  凹部
 35  入口管
 35a 入口部
 36  出口管
 36a 出口部
 37  バルーン用管
 37a 流体導入部
 40  注入ルーメン
 41  吸引ルーメン
 42  拡張ルーメン
 50  液体供給部
 52  髄液回収部
 53  拡張用流体供給部
10 Catheter 20 Tube body 21 Balloon 22 Cranial pressure sensor 30 Injection port 31 Suction port 33 Recess 35 Inlet tube 35a Inlet 36 Outlet tube 36a Outlet 37 Balloon tube 37a Fluid introduction 40 Injection lumen 41 Suction lumen 42 Expansion lumen 50 Liquid Supply unit 52 Spinal fluid collection unit 53 Expansion fluid supply unit

Claims (7)

  1.  生体内に挿入される管本体を有するカテーテルであって、
     前記管本体は基端部に流体の入口部と出口部とを有し、
     前記入口部は前記管本体の先端部に形成される注入口と連通し、
     前記出口部は前記注入口より基端側に設けられる吸引口と連通し、
     前記管本体を生体に押圧するバルーンを有するカテーテル。
    A catheter having a tube body that is inserted into the living body.
    The pipe body has a fluid inlet and outlet at the base end, and has a fluid inlet and outlet.
    The inlet portion communicates with an injection port formed at the tip end portion of the pipe body, and communicates with the injection port.
    The outlet portion communicates with a suction port provided on the proximal end side of the injection port.
    A catheter having a balloon that presses the tube body against a living body.
  2.  前記吸引口は前記管本体の長さ方向に沿って複数形成される請求項1に記載のカテーテル。 The catheter according to claim 1, wherein a plurality of suction ports are formed along the length direction of the tube body.
  3.  前記入口部は液体供給部に接続され、前記出口部は髄液回収部に接続される請求項1または2に記載のカテーテル。 The catheter according to claim 1 or 2, wherein the inlet portion is connected to a liquid supply portion and the outlet portion is connected to a cerebrospinal fluid collection unit.
  4.  前記バルーンは、前記吸引口より基端側に設けられる請求項1~3のいずれか1項に記載のカテーテル。 The catheter according to any one of claims 1 to 3, wherein the balloon is provided on the proximal end side of the suction port.
  5.  前記バルーンは前記吸引口の近傍位置であって、前記吸引口と同じ周方向位置に設けられる請求項4に記載のカテーテル。 The catheter according to claim 4, wherein the balloon is located near the suction port and is provided at the same circumferential position as the suction port.
  6.  前記管本体は、先端部に頭蓋内圧センサーを有する請求項1~5のいずれか1項に記載のカテーテル。 The catheter according to any one of claims 1 to 5, wherein the tube body has an intracranial pressure sensor at the tip.
  7.  前記管本体は、先端部に酸素濃度センサーを有する請求項1~6のいずれか1項に記載のカテーテル。 The catheter according to any one of claims 1 to 6, wherein the tube body has an oxygen concentration sensor at the tip thereof.
PCT/JP2021/001476 2020-03-27 2021-01-18 Catheter WO2021192538A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020058236A JP2023062710A (en) 2020-03-27 2020-03-27 catheter
JP2020-058236 2020-03-27

Publications (1)

Publication Number Publication Date
WO2021192538A1 true WO2021192538A1 (en) 2021-09-30

Family

ID=77891370

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/001476 WO2021192538A1 (en) 2020-03-27 2021-01-18 Catheter

Country Status (2)

Country Link
JP (1) JP2023062710A (en)
WO (1) WO2021192538A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023181979A1 (en) * 2022-03-23 2023-09-28 テルモ株式会社 Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5195955A (en) * 1989-11-14 1993-03-23 Don Michael T Anthony Device for removal of embolic debris
EP1060758A1 (en) * 1999-06-15 2000-12-20 Medtronic, Inc. Aortic occlusion cannula
JP2003250899A (en) * 2002-03-05 2003-09-09 Osamu Kato Liquid medicine injection catheter
JP2006511292A (en) * 2002-12-23 2006-04-06 ボストン サイエンティフィック リミテッド Method and apparatus for advancing the subarachnoid space
JP2006511284A (en) * 2002-12-23 2006-04-06 ボストン サイエンティフィック リミテッド Guide catheter introduced into subarachnoid space and method of using the same
JP2016172087A (en) * 2006-10-09 2016-09-29 ニューロフルーディクス, インコーポレイテッド Cerebrospinal fluid purification system
JP2018529473A (en) * 2015-10-06 2018-10-11 ミネトロニクス, インコーポレイテッド Apparatus and method for providing local cooling to the brain and spinal cord

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5195955A (en) * 1989-11-14 1993-03-23 Don Michael T Anthony Device for removal of embolic debris
EP1060758A1 (en) * 1999-06-15 2000-12-20 Medtronic, Inc. Aortic occlusion cannula
JP2003250899A (en) * 2002-03-05 2003-09-09 Osamu Kato Liquid medicine injection catheter
JP2006511292A (en) * 2002-12-23 2006-04-06 ボストン サイエンティフィック リミテッド Method and apparatus for advancing the subarachnoid space
JP2006511284A (en) * 2002-12-23 2006-04-06 ボストン サイエンティフィック リミテッド Guide catheter introduced into subarachnoid space and method of using the same
JP2016172087A (en) * 2006-10-09 2016-09-29 ニューロフルーディクス, インコーポレイテッド Cerebrospinal fluid purification system
JP2018529473A (en) * 2015-10-06 2018-10-11 ミネトロニクス, インコーポレイテッド Apparatus and method for providing local cooling to the brain and spinal cord

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023181979A1 (en) * 2022-03-23 2023-09-28 テルモ株式会社 Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices

Also Published As

Publication number Publication date
JP2023062710A (en) 2023-05-09

Similar Documents

Publication Publication Date Title
US10932810B2 (en) Thrombectomy catheter systems
US11534592B2 (en) Systems and methods for drug delivery, treatment, and monitoring
US10058679B2 (en) Assemblies, systems, and methods for infusing therapeutic agents into the body
CA2467406C (en) Drug delivery catheter assembly with inflatable balloon
US10898693B2 (en) Nasal delivery of agents with nested balloon catheter
US20130158506A1 (en) Catheter and needle system and method of inserting a catheter
JP2011519679A (en) Devices and methods for delivering therapeutic agents
US20060184098A1 (en) Subarachnoid spinal catheter for transporting cerebrospinal fluid
WO2021192538A1 (en) Catheter
KR101089348B1 (en) Balloon catheter for injecting medicine and medicine injection apparatus comprising the same
WO2021192539A1 (en) Catheter and catheter system
US8277410B2 (en) Methods and apparatus for inhibiting introduction of air into the vasculature during a percutaneous procedure
US11540858B2 (en) Multi-lumen arthroscopy cannula (MLAC) and methods of use
US20150018873A1 (en) Balloon catheter
CN210844890U (en) Balloon catheter capable of passing through guide wire under guidance of endoscope
WO2022070482A1 (en) Catheter, and device for treating cerebral infarction
WO2022181126A1 (en) Treatment device for cerebrovascular disorders
WO2023181979A1 (en) Therapeutic device for brain diseases, connector for therapeutic devices, and connector fixing tool for therapeutic devices
JP2021154073A (en) Cure system
US20090221959A1 (en) Elongated medical apparatus with inflatable tip
MX2008004321A (en) Trocar-cannula complex, cannula and method for delivering fluids during minimally invasive surgery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21774503

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21774503

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP